Versigent Plc (VGNT.N): Solid Execution, Non-Auto Upside Still Underappreciated

VGNT delivered $275m of adj. EBITDA (+11% Y/Y), with margins up 40 bps to 11.2% and adj. EPS of $1.91 versus our $1.68 estimate and consensus of $1.78. Revenue grew 7% to $2.45bn, although growth ex-FX and commodities was ~1%, while the company maintained or narrowed its earnings outlook and raised FCF guidance to a $300m midpoint from $250m, with management attributing the increase primarily to timing and leaving the ~$1bn cumulative 2026-28 FCF target unchanged. Elevated launches continue into 4Q and will weigh on margins, with management pointing to the ~10.4% full-year margin implied by guidance as the more appropriate starting point for the 2027 bridge. Higher commodity costs and China demand/exports remain key risks. We lower our 2027 adj. EBITDA ~3% to $1,066mn on a more conservative 10.6% margin assumption and cut our price target to $54 from $58, reflecting a lower 5.0x EV/EBITDA multiple amid rising macro uncertainty. We reiterate Overweight, as we believe the market and valu